Interaction of Cutibacterium (formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development by Aubin, G.G. et al.
1Scientific RepoRts | 7:42918 | DOI: 10.1038/srep42918
www.nature.com/scientificreports
Interaction of Cutibacterium 
( formerly Propionibacterium) acnes 
with bone cells: a step toward 
understanding bone and joint 
infection development
Guillaume Ghislain Aubin1,2, Marc Baud’huin3,4, Jean-Philippe Lavigne5,6, Régis Brion3,4, 
François Gouin3,7, Didier Lepelletier1,2, Cédric Jacqueline1, Dominique Heymann3,4,8, 
Karim Asehnoune1 & Stéphane Corvec2,9
Cutibacterium acnes (formerly Propionibacterium acnes) is recognized as a pathogen in foreign-body 
infections (arthroplasty or spinal instrumentation). To date, the direct impact of C. acnes on bone cells 
has never been explored. The clade of 11 C. acnes clinical isolates was determined by MLST. Human 
osteoblasts and osteoclasts were infected by live C. acnes. The whole genome sequence of six isolates 
of this collection was analyzed. CC36 C. acnes strains were significantly less internalized by osteoblasts 
and osteoclasts than CC18 and CC28 C. acnes strains (p ≤ 0.05). The CC18 C. acnes ATCC6919 isolate 
could survive intracellularly for at least 96 hours. C. acnes significantly decreased the resorption ability 
of osteoclasts with a major impact by the CC36 strain (p ≤ 0.05). Genome analysis revealed 27 genes 
possibly linked to these phenotypic behaviors. We showed a direct impact of C. acnes on bone cells, 
providing new explanations about the development of C. acnes foreign-body infections.
Bone is a mineralized tissue constantly remodeled under the simultaneous coordinated action of three cell types: 
bone matrix-resorbing osteoclasts, bone matrix-forming osteoblasts, and osteocytes embedded in the mineral-
ized bone matrix1. This physiological process is tightly regulated and crucial to maintain a constant bone mass in 
adults. However, this balance can be impaired to favor resorption in pathological conditions, such as osteoporosis 
or bone and joint infection (BJI). The pathogenicity of Cutibacterium acnes has long been restricted to skin con-
ditions2. However, C. acnes is increasingly recognized as a pathogen, mainly in foreign-body infections, such as 
arthroplasty or spinal instrumentation-associated infections3,4. The role of C. acnes in foreign-body infections is 
probably underestimated because, as an anaerobe, it needs an adapted bacterial transport system and usually a 
prolonged incubation time of up to 14 days for growth5. Late growth and/or growth only in enrichment media are 
often misinterpreted as contamination6. Recognition of the pathogenicity of C. acnes in such cases is dependent 
on its recovery in multiple, separately collected perioperative samples from a site expected to be sterile, in associa-
tion with clinical symptoms7. Unfortunately, the clinical diagnosis of such low-grade infection can be challenging 
because these infections often mimic aseptic loosening with scarce or nonspecific clinical signs and symptoms8. 
The absence of a gold standard for the diagnosis and accurate criteria to define foreign-body infection may 
explain why C. acnes torpid infections are sometimes misclassified as aseptic loosening or mechanical failure9.
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Therefore, the association between implant surgery and C. acnes infection is not always obvious10 and different 
studies have focused on population genetics and sequence typing in an attempt to identify sub-populations with 
different pathogenic potential11–16. To date, no clear association between phylotypes and infection/colonization 
has been reported. A genetic analysis of 210 C. acnes isolates from various origins demonstrated that phylotypes 
IB, II and III were more often associated with blood, cerebrospinal fluid and prosthetic hip infections whereas 
phylotype IA strains were highly associated with acne13. IB strains have also been more frequently isolated from 
infected prostheses than IA strains 17. Although several typing methods have been developed for C. acnes, whole 
genome-based typing reveals that only MLST methods have the discriminatory power to identify all distinct 
subtypes13. Recently, Yu et al. stated that studies focusing on well characterized types may further increase our 
understanding of the role of different C. acnes types in the pathogenesis of disease18.
Based on this statement, and because the direct impact of C. acnes isolates on bone cells has never been 
explored, we investigated the sequence type (ST) of C. acnes clinical isolates and developed different models in 
order to study the interaction between C. acnes and bone cells (osteoblasts or osteoclasts). Finally, whole genome 
sequencing (WGS) analysis revealed genetic tracks to explain the C. acnes behaviors observed.
Material and Methods
Bacterial strains. Eleven C. acnes clinical isolates (11 patients) were selected from a large collection of 
strains, including the main phylotypes and clonal complexes, mostly from previous studies19,20. Four isolates were 
recovered from monomicrobial spinal instrumentation infections, two from prosthetic monomicrobial infec-
tions, three from acne lesions and two were reference strains (ATCC11827 and ATCC6919). The characteris-
tics of the selected isolates are summarized in Table 1. Implant-associated infections were confirmed using the 
Infectious Diseases Society of America criteria for bone and joint infections21.
Molecular methods. Clonality. Multi-Locus Sequence Typing (MLST) was carried out on all isolates as 
described by Lomholt et al.13. This scheme is based on partial sequences of nine housekeeping genes comprising 
a total of 4,287 nucleotides and is available at http://pacnes.mlst.net/.
Whole genome sequencing. To investigate the relationship between phenotypic and genotypic results, WGS was 
performed on a subset from our collection. Five isolates were selected depending on their sequence type and clin-
ical origin (Table 1). Bacterial DNA was extracted according to the manufacturer’s protocol using the commercial 
extraction kit QIAamp® DNA mini kit (Qiagen, Hilden, Germany). Genome sequencing was performed using 
the MiSeq (Illumina) sequencing technology22. The genome alignment of C. acnes isolates was visualized using 
a progressive Mauve algorithm in the Mauve program version 20150226 build 1023. C. acnes genome sequences 
were annotated using the Rapid Annotation Subsystem Technology (RAST) automated web service24. Figure for 
genome comparison was generated by BRIG software25 and OAT software26.
Co-culture with bone cells. Before infection of the bone cell cultures, strains were grown overnight at 37 °C 
in 40 mL of Brain Heart Infusion (BHI, Oxoid, Dardilly, France), harvested by centrifugation for 10 min at 800 g 
and washed once in 5 mL of phosphate-buffered saline (PBS). The pellets were suspended in 5 mL of Dulbecco’s 
Modified Eagle’s Medium (DMEM; Invitrogen-Life Technologies, Inc.). Bacterial suspensions were adjusted with 
a nephelometer to obtain 1 × 108 CFU mL−1 and then diluted in DMEM.
Human osteoblast cultures. The human osteosarcoma cell line MG-63 purchased from ATCC was cultured in a 
5% CO2 atmosphere at 37 °C in DMEM supplemented with 5% of fetal bovine serum (Hyclone Perbio, France). 
Three days before infection, cells were seeded in 24-well culture plates to obtain confluent monolayers. To confirm 
the results obtained with MG-63 cells, the same method was applied with two representative isolates (ATCC6919 
and BL strains) on human mesenchymal stem cells (hMSC). hMSC were obtained from healthy donors. Blood 
draws were performed at the “Etablissement Français du Sang” (Nantes, France) after obtaining the informed 
consent of all healthy donors. The experimental protocol was approved by the ethics committee of the Medical 
Isolate name Clinical source Clonal complex MLST Phylotype (recA type) Internalization level
ATCC11827 Acne CC18 IA < 0.01%
ATCC6919*¥ Acne CC18 IA > 1%
PA PP Acne CC28 IB > 1%
PA HB* Acne CC18 IA > 1%
PA NL Acne CC36 IB < 0.01%
PA 2004-8219 Spine CC28 IB > 1%
PA 2006-3267 Spine CC36 IB < 0.01%
PA 2003-1719* Spine CC28 IB > 1%
PA 2004-10708* Spine CC18 IA > 1%
PA BL*¥ Hip prosthesis CC36 IB < 0.01%
PA Ntes* Knee prosthesis CC18 IA > 1%
Table 1.  Characteristics of Cutibacterium acnes selected for whole genome sequencing and internalization 
assay. *Isolates selected for WGS. ¥Isolates selected for mesenchymal stem cell internalization assay.
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School of Nantes. All experiments were performed in accordance with the Good Scientific Practice guidelines 
of the Medical School of Nantes and all relevant guidelines and regulations. hMSC were cultured in DMEM 
supplemented with 10% of fetal bovine serum, 1 ng/mL of basic Fibroblast Growth Factor (bFGF; R&D systems, 
UK), 100 U/mL of penicillin/streptomycin, and 2 mM L-glutamine. Adherent cells were frozen at passage 2 after 
characterization by flow cytometry (CD45− , CD34− , CD105+ , CD73+ , and CD90+ , purity ≥ 99%) prior to 
further experiments27.
Internalization assay. Bacterial internalization experiments were adapted from Crémet et al. study28. Briefly, 
the MG-63 monolayers were infected for 2 h (multiplicity of infection (MOI) of 100:1). The number of bacteria 
present in the inocula was checked by plating dilutions on Schaedler plates incubated under anaerobic conditions. 
After 2 h of infection, cells were washed twice with PBS and incubated for a further 2 h in 1 mL of DMEM con-
taining 1% of penicillin/streptomycin to kill the remaining extracellular bacteria. The cell monolayers were then 
washed three times and lysed with 0.1% Triton X-100. The lysates were serially diluted and plated on Schaedler 
plates to count the number of intracellular bacteria. The results were expressed as percentages of inoculum.
Bacterial internalization assessment by cell staining and confocal microscopy. To confirm the bacterial internal-
ization, MG-63 cells were seeded onto slides after the internalization assay and then Gram and Giemsa stained. 
For live confocal microscopy, MG-63 cells were seeded onto Ibidi® μ -Slide 18 well (Munich, Germany) and 
infected with two selected clinical strains (ATCC6919 and BL), as described above. Fluorescein isothiocyanate 
(Sigma-Aldrich®, Saint Quentin Fallavier, France) was used to visualize the bacteria, along with calcein red/
orange (Thermo Fischer Scientific, Waltham, MA USA) to label the cellular membrane. Slides were acquired on 
a Nikon A1 Rsi confocal microscope designed for live cell imaging using an Okolab environmental chamber to 
regulate temperature and air/CO2/N2. Pictures were analyzed with Fiji software29. 3D images were processed with 
NIS elements (Nikon Instruments Inc.) and Volocity 3D Image Analysis Software (PerkinElmer).
Persistence assay. ATCC6919 and BL C. acnes strains were internalized in MG-63 cells as described above. 
Following incubation with penicillin/streptomycin, MG-63 cells were lysed at 12, 24, 48, 72, 96 and 168 h 
post-infection to assess intracellular bacterial viability and persistence. Lysates were seeded on Schaedler plates. 
Bacterial growth was observed after five days of incubation at 37 °C under anaerobic atmosphere conditions.
Cell viability and osteoclastogenesis assay. The generation of osteoclasts from human CD14+ monocytes has 
been described previously30. Briefly, purified CD14+ cells from different healthy donors were cultured in α -MEM 
with 10% FCS and 25 ng/mL human M-CSF (R&D systems). Blood draws were performed at the “Etablissement 
Français du Sang” (Nantes, France) after obtaining the informed consent of all healthy donors. The experimental 
protocol was approved by the ethics committee of the Medical School of Nantes. All experiments were performed 
in accordance with the Good Scientific Practice guidelines of the Medical School of Nantes and all relevant guide-
lines and regulations. At day 3, cells were infected with C. acnes as described above (MOI 10:1), followed by anti-
biotic treatment for 2 h and addition of 100 ng/mL RANKL. Multinucleated cells formed with 3 or more nuclei 
were counted after TRAP staining (Sigma, France). Cell growth was measured using the crystal violet assay as 
described previously30.
Bone resorption assay. Mature osteoclasts were obtained by differentiation of CD14+ cells and then infected 
by C. acnes as described above (MOI 10:1), followed by antibiotic treatment for 2 h. Next, cells were incubated 
for 48 h on 96-well Corning Osteo Assay® plates (OsteoCorning, Corning, MA). After the culture period, cells 
were removed with bleach solution and the area of resorption pits was quantified using Image J software (NIH, 
Bethesda, MD).
Results
C. acnes belonging to clonal complex 36 are less internalized by human osteoblast-like cells. 
The bacterial internalization assay by osteoblasts was carried out using 11 C. acnes strains. Clonal complexes of 
these isolates are shown in Table 1. CC36 C. acnes strains were less invasive than CC18 and CC28 C. acnes strains 
toward osteoblasts (mean percentage of internalized bacteria < 0.01% for CC36 P. acnes strains versus more than 
1% for CC18 and CC28 C. acnes strains (Fig. 1A)). The ATCC11827 CC18 C. acnes strain exhibited a similar 
invasiveness to CC36 isolates (Fig. 1A). To assess whether the observed results were not related to the nature of 
osteosarcoma MG-63 cells, we confirmed our results using mesenchymal stem cells. These had the advantage of 
sharing common features with all bone cells and enabled the results observed to be extrapolated to all derivative 
cells. The mean percentages obtained previously were similar for both isolates: CC18 ATCC6919 and CC36 BL 
C. acnes (Fig. 1B). Using these two isolates, the same results were also observed for the interaction, especially with 
osteoclasts (Fig. 1B). Determination of bacterial subcellular localization by Gram staining (Fig. 1C) and confocal 
microscopy (after stringent washing to remove unattached bacteria) confirmed the intracellular presence of 
C. acnes and the discrepancies observed between the clonal complexes (Fig. 1D,E, Supplementary data video 1).
C. acnes can survive in human osteoblast cells. Low-grade and chronic infections can be due to bacte-
ria hidden from the immune response, inside cells. Herein, as C. acnes isolates demonstrated different osteoblast 
internalization abilities, we further evaluated whether CC18 ATCC6919 and CC36 BL C. acnes strains under-
went clearance by osteoblasts. As shown in Fig. 2, the CC18 ATCC6919 strain could survive in osteoblasts after 
96 h of incubation. A significant decrease in the number of viable intracellular bacteria was observed during the 
course of the experiment (p = 0.0007). The mean CFU/well ranged from 1.15 × 104 at time 0 to 17.3 after 96 h of 
incubation. No colony remained at Day 7. In contrast, no colony remained at 24 h with the CC36 BL strain. These 
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results demonstrate the ability of C. acnes strains to remain viable intracellularly at least 96 h after infection, in 
our experimental model.
C. acnes infection has no impact on osteoclastogenesis. We then evaluated whether bacterial infec-
tion of the precursors could impact osteoclastogenesis. Cell viability was not significantly changed in any of 
the subgroups (Fig. 3A). Human CD14+ monocytes were cultured in control conditions or in the presence of 
ATCC6919 or CC36 BL C. acnes for 2 h. Seven days after internalization of ATCC6919 or CC36 BL C. acnes, a 
mean (± SD) of 382 ± 100 and 290 ± 6 of the cells, respectively, were multinucleated and TRAP-positive, com-
pared with uninfected cells (416 ± 67) (Fig. 3B).
Figure 1. Host cell type-specific internalization of Cutibacterium acnes. (A) MG-63 cells were infected with 
different C. acnes strains at a MOI of 100:1 for 2 hours. After 2 h, cells were washed, treated with penicillin/
streptomycin, washed again and lysed. CFU counts were determined after 5 days of anaerobic culture of the 
lysate on Schaedler plates. *P < 0.01. (B) MG-63 cells, osteoclasts (OC) and mesenchymal stem cells (MSC) 
were infected with different C. acnes strain at a MOI of 100:1 for 2 hours. After 2 h, cells were washed, treated 
with penicillin/streptomycin, washed again and lysed. CFU counts were determined after 5 days of anaerobic 
culture of the lysate on Schaedler plates. **P < 0.01. (C) MG-63 cells Gram stained (ATCC6919 C. acnes 
cells appear in purple). (D) Live confocal microscopy pictures after 2 h of incubation with MG-63 cells and 
washing. MG-63 cell membranes were stained with calcein red/orange (red). C. acnes bacteria were stained 
with fluorescein isothiocyanate (green). D1. Result with C. acnes ATCC6919 strain. D2. Result with C. acnes BL 
isolate. (E) Orthogonal views from different planes (x/y, x/z or y/z) of the live confocal microscopy images used 
to analyze the ATCC6919 CC18 C. acnes location. Bacteria (FITC, green) inside the cell (cellular membranes, 
stained with calcein red/orange, appear in red) are indicated by a white arrow.
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C. acnes strains inhibit osteoclast bone resorption capacities. We then decided to evaluate the 
impact of C. acnes infection on mature osteoclast function. The mean percentage of the resorbed area (± SD) by 
cells infected with CC18 ATCC6919 or CC36 BL C. acnes strains was 9.6 ± 0.53% and 7 ± 1.9%, respectively. A 
significant difference (p < 0.05) was observed between uninfected wells (12 ± 1.7%) and C. acnes infected wells 
after 48 h of resorption. Moreover, CC36 C. acnes showed a more significant ability to decrease the resorption 
ability of osteoclasts than the CC18 ATCC6919 strain (p < 0.05). The results of the most representative experi-
ment are presented in Fig. 3C,D.
Whole genome sequencing. WGS was performed on a subset of isolates to highlight candidate genes 
potentially involved in the differences in phenotypic behavior observed previously (Table 1). The ATCC6919, 
BL, Ntes, HB, 2003-1719 and 2004-10708 strains yielded 2617, 2469, 2416, 2410, 2463 and 2410 predicted coding 
Figure 2. Persistence and viability of C. acnes strain ATCC6919 (CC18) and C. acnes BL (CC36) after 
internalization by MG-63 osteosarcoma cells. The mean CFU for three independent experiments for each 
time point is shown. Vertical lines represent the 95% confidence interval.
Figure 3. Impact of Cutibacterium acnes on the osteoclast lineage. (A) Cell viability after infection of human 
CD14+ monocytes by C. acnes. NS: not significant. (B) Effect of infection of human CD14+ monocytes by  
C. acnes on osteoclastogenesis. Multinucleated cells formed with 3 or more nuclei (osteoclasts) were counted 
after TRAP staining. NS: not significant. (C) Resorption pit area due to mature osteoclasts uninfected (Ca), 
infected by C. acnes ATCC6919 (Cb), and infected by C. acnes BL (Cc). (D) Percentage of matrix resorbed by 
mature osteoclasts uninfected (control), or infected by C. acnes after 48 hours of culture. *P < 0.05 (one-tailed 
t-test).
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sequences (CDSs), respectively31,32. Slightly less than half (44 to 47%) of the CDSs in each strain could be func-
tionally categorized into 315 to 331 subsystems. Among the subsystems, carbohydrates, “cofactors, vitamins, 
prosthetic groups, pigments”, “amino acids and derivatives” and protein metabolism had the greatest number of 
genes. An overview of the genome characteristics of the isolates and their subsystem statistics is shown in Table 1 
of the supplementary data. The SEED viewer identified 27 genes that were specific to the non-internalized isolates 
and 6 genes specific to the internalized isolates (Fig. 4, Table 2 in the supplementary data).
Discussion
Most studies on the interaction between bacteria and bone cells during foreign-body infection have focused on 
the Staphylococcus aureus model, the main pathogen isolated in this context33–35. Very few other species have 
been studied and little is known about the impact of C. acnes either in aseptic loosening or low-grade infection36. 
In fact, C. acnes host-pathogen interactions have only been well demonstrated in the acne field, with a specific 
cutaneous innate immunity pattern according to phylotype37. To the best of our knowledge, this study is the first 
to provide information about the interaction and relationship between C. acnes and bone cells, in line with clinical 
and molecular typing data. Herein, using different lineages of C. acnes, we showed that strains belonging to the 
lineage previously associated with PJI (phylotype IB, CC36) were significantly less internalized by bone cells than 
those belonging to the lineage previously associated with acne or spine instrumentation infections (phylotype 
IA, CC18/CC28)13,17. We also showed that C. acnes can decrease the resorption ability of osteoclast with a greater 
effect of C. acnes belonging to CC36.
As shown in Fig. 5, both osteoblast and osteoclast interactions were studied to take into account the overall 
impact of this bacterium on the bone remodeling process. Osteoblasts, derived from mesenchymal bone marrow 
precursors, control this process by synthesizing the components of the bone matrix and by modulating the activ-
ity of the bone-resorbing osteoclasts1. Although bone cells can internalize bacteria by different mechanisms, i.e., 
phagocytosis for osteoclasts or endocytosis for osteoblasts38,39, interestingly, we observed a similar internalization 
behavior in response to C. acnes infection with osteoblasts, human mesenchymal stem cells (precursors of osteo-
blasts derived from bone marrow) and osteoclasts.
Using different epithelial cells, Mak et al. showed that a ST33/CC36 C. acnes strain (isolated from a prosta-
tectomy tissue sample) was more internalized in RWPE1 cells than in HaCaT and HEKa cells40. Unfortunately, 
this could not be compared with our internalization level because only a relative invasion percentage was pro-
vided. On the other hand, two CC36 strains (P6 from cancerous prostate and KPA171202) and one CC18 strain 
(P266, pleuropulmonary isolate) showed strain-dependent differences in their uptake by the THP-1 cell line 
(macrophage model)41, without any correlation to the clade (45.9% and 8.9% of the initial inoculum for KPA and 
P6 strains, respectively). Taken together, these studies suggest that the CC36 strain trait observed is linked to the 
bone origin of the cells used in our study.
From a pathophysiological point of view, the evasion mechanism observed for CC36 C. acnes isolates could 
allow this clade to leave the site of infection, disseminate into deeper tissue layers and cause PJI (i.e., arthroplasty 
Figure 4. Core and pan-genome analysis of Cutibacterium acnes strains. (A) General comparison of the 
whole genome sequence of C. acnes generated with OrthoANI values calculated from OAT (Orthologous 
Average Nucleotide Identity Tool) software (http://www.ezbiocloud.net/app). (B) Comparison of C. acnes 
genomes. The RAST-annotated genomes of 6 C. acnes isolates (ATCC6919, HB, 2003-1719, 2004-10708, BL and 
Ntes) were aligned using C. acnes KPA171202 as a reference sequence. The genomes were aligned and the figure 
was created with BRIG software (http://brig.sourceforge.net/). Red arrows outside the outer circle indicate the 
locations of non-internalized strain-specific genes, blue arrows indicate the locations of internalized strain-
specific genes.
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infection). Inside the deeper tissue, close to the material, the local immune defect fosters the low-grade infections 
observed42. In contrast, for CC18 and CC28 clades, mostly involved in spinal instrumentation infection, the inter-
nalization process observed could allow them to escape from the numerous immune cells located under the skin43 
and generate an infection locally, favored by the spine instrumentation close to the skin. Moreover, the failure of 
osteoblasts to eradicate the intracellular CC18 C. acnes clade, resulting in bacterial persistence in the host, could 
explain the clinically observed BJI chronicity.
Additionally, we showed that direct infection of mature osteoclasts with C. acnes decreases their bone resorp-
tion ability. In vivo, a decrease in bone resorption will unbalance the bone remodeling process, leading to the 
possible aseptic loosening observed during C. acnes infection44. Interestingly, the CC36 C. acnes clade showed a 
major impact on osteoclast bone resorption ability. This result constitutes another argument to explain the deeper 
infection (PJI) tropism of CC36 C. acnes clades.
Finally, WGS analysis confirmed the high genome coverage and the highly stable chromosome previously 
observed45,46. All indels observed and linked to clade features (and most likely internalization) were recently 
described by Scholz et al.45. We identified 27 genes possibly linked to the behaviors observed (Table 2 in supple-
mentary data). Perhaps the best candidate to explain our results is the hyaluronate lyase gene (indel_14)45. Indeed, 
the study of Tyner et al.47 and the recent communication from Nunes et al.48 highlighted that the allele diversity 
in the hyaluronate lyase gene could lead to different enzyme activities modulating, de facto, the penetration of 
C. acnes into tissues rich in hyaluronic acid (e.g. joints).
In conclusion, our study provides new data about C. acnes interactions with bone cells. Its strength is that it 
addresses the two main agents of the bone remodeling process with bacteria perfectly genetically defined due 
to the most recent molecular tools. We clearly identify two C. acnes behaviors depending on their genetic back-
ground (CC). These two behaviors provide explanations about the development of C. acnes PJI or spine instru-
mentation infection.
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